Used primarily as an intermediate in pharmaceutical synthesis, this compound plays a key role in the production of immunomodulatory drugs. It is notably involved in the preparation of derivatives that target protein degradation pathways, especially cereblon E3 ligase modulators, which are important in cancer therapy. Its structure allows for selective binding and modification of biological targets, making it valuable in developing treatments for multiple myeloma and other hematological cancers. Additionally, it is used in research settings to design novel proteolysis-targeting chimeras (PROTACs), which enable targeted protein degradation within cells.